1. Home
  2. EW vs HLN Comparison

EW vs HLN Comparison

Compare EW & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$86.53

Market Cap

46.0B

Sector

Health Care

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$11.06

Market Cap

43.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EW
HLN
Founded
1958
2022
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Specialties
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
46.0B
43.7B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
EW
HLN
Price
$86.53
$11.06
Analyst Decision
Buy
Buy
Analyst Count
21
1
Target Price
$96.47
N/A
AVG Volume (30 Days)
4.8M
8.0M
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
1.69%
EPS Growth
N/A
N/A
EPS
1.83
N/A
Revenue
$6,067,600,000.00
N/A
Revenue This Year
$13.19
$1.62
Revenue Next Year
$9.81
$4.39
P/E Ratio
$46.85
$49.05
Revenue Growth
11.55
N/A
52 Week Low
$65.94
$8.71
52 Week High
$87.89
$11.42

Technical Indicators

Market Signals
Indicator
EW
HLN
Relative Strength Index (RSI) 66.06 56.96
Support Level $81.61 $9.59
Resistance Level $87.20 $11.35
Average True Range (ATR) 2.46 0.16
MACD 1.09 -0.06
Stochastic Oscillator 96.83 78.57

Price Performance

Historical Comparison
EW
HLN

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: